The latest lymphoma news
Ingo Ringshausen, University of Cambridge Cancer of the immune system, lymphoma or leukaemia, generally affects…
Findings may create immunotherapy options for lymphomas caused by CREBBP mutations A study at The…
Combining a new anti-cancer drug targeting Mcl-1 with current cancer therapies could be an effective…
A new, experimental immunotherapy can put patients with B-cell non-Hodgkin lymphoma (NHL) that is resistant…
A new analysis shows that a donor stem cell transplant following treatment with an immune…
Older adults with blood cancers can benefit from a team-based, holistic evaluation before undergoing transplantation,…
What if you could cure cancer by re-engineering patients’ cells to better target and destroy…
For decades, a transcription factor known as STAT3 has been a major therapeutic target in…
Natural killer T cell lymphoma (NKTL) is an aggressive form of cancer with very poor…
The discovery of the UM171 molecule, by Dr. Guy Sauvageau and Anne Marinier, made headlines…